Registration: 5:00 - 6:00 pm
Dinner and Program: 6:00 - 9:00 pm
This program is supported by Janssen Biotech, Inc., Merck, and the Norbert Schnog Endowment.
Agenda:
Muscle Invasive v. Non-Muscle Invasive Bladder Cancer: Case Studies
Checkpoint Treatment for BCG Refractory, Unresponsive Disease
Patrick A. Kenney, MD, Assistant Professor of Urology
Bladder Sparing Chemo-Radiation
James B. Yu, MD, MPH, Associate Professor of Therapeutic Radiology
Neoadjuvant Therapy for Locally Advanced Bladder Cancer
Michael Leapman, MD, Assistant Professor of Urology
Novel Agents for Advanced Bladder Cancer
Daniel P. Petrylak, MD, Professor of Medicine (Medical Oncology) and Urology
Understanding the Subtypes and Aberrant Histologies of Urothelial Carcinomas
Peter A. Humphrey, MD, PhD, Professor of Pathology
The Yale School of Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.